News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Chloroquine for COVID-19: Cutting Through the Hype
Chris Baraniuk | Mar 20, 2020
President Donald Trump has touted the drug as a treatment but scientists still don’t know for sure that it is effective in patients. A number of clinical trials aim to find out.
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
Catherine Offord | May 27, 2020
A paper published in
reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.
Journal Publisher Concerned over Hydroxychloroquine Study
Kerry Grens | Apr 9, 2020
The report by Didier Raoult and colleagues that examined the use of the anti-malarial drug in a small number of COVID-19 patients receives criticism from the very society that published it.
The Many Model Systems of COVID-19
Abby Olena | Nov 4, 2020
Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.
FDA Pulls Emergency Use Authorization for Antimalarial Drugs
Amanda Heidt | Jun 16, 2020
Hydroxychloroquine and chloroquine, once thought to be promising COVID-19 treatments, come with serious heart risks.
Opinion: Scientists Must Battle the Disinformation Pandemic
Genna Reed | Oct 1, 2020
Fighting the spread of an infectious disease goes hand in hand with stemming the dissemination of lies, bad science, and misdirection.
Cheap, Safe Anti-Malaria Drug Reduces Zika Virus in Mice
Kerry Grens | Nov 17, 2017
Infected animals given chloroquine while pregnant had fetuses with a far lighter viral load in their brains than untreated mice did.
Chloroquine Protects Against Zika In Vitro
Marcia Triunfol | May 12, 2016
The antimalarial drug reduces the number of infected Vero and human brain microvascular endothelial cells—among other cell types—in culture, researchers report in a preprint.
Disputed Hydroxychloroquine Study Brings Scrutiny to Surgisphere
Catherine Offord | May 30, 2020
Scientists have raised questions about the dataset published in
last week that triggered the suspension of clinical trials around the world—and about Surgisphere Corporation, the company behind the study.
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Feb 28, 2019
has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.
Refine your Search